Devices for Restless Legs Syndrome

A practical research brief for a person whose RLS remains severe despite improved iron levels and whose necessary medication may worsen symptoms.

Prepared September 2026 · U.S. options plus overseas/non-FDA options · Not medical advice

Contents

Bottom line
U.S. prescription devices
Overseas and non-FDA options
Other devices and what the evidence means
Safety and medication review
Questions for his clinician
Sources

1. Bottom line

Most promising

Nidra / TOMAC nerve stimulation

The best-supported device option is a prescription wearable that stimulates both peroneal nerves below the knees. It is specifically intended for adults with moderate-to-severe medication-refractory primary RLS. It is expensive and access varies by state and insurer.

Lower-cost trial

Restiffic foot orthosis

A prescription foot wrap applies targeted pressure to muscles in the foot. It has FDA De Novo authorization and is much simpler than Nidra, but the evidence base is smaller and long-term data are limited.

Overseas options

TheraPulse and Relegs

Both are/ were European electrical or vibration devices marketed for RLS. TheraPulse appears to have a current UK storefront. Relegs has credible historical reporting of CE certification, but I could not verify a dependable current retail channel. CE marking is not the same as FDA clearance or proof of high-quality clinical benefit.

2. U.S. prescription devices

Device	How it works	Evidence / access	Main cautions
Nidra / NTX150 TOMAC Best evidence	Two wearable units stimulate the common peroneal nerves near the fibular heads, producing sustained, mild muscle activation without making the legs visibly move.	FDA De Novo Class II device. The AASM conditionally recommends bilateral high-frequency peroneal nerve stimulation. Prescription only; U.S. controlled release. Manufacturer lists about $7,500 plus about $75/month for replacement electrode interfaces. Insurance is case-by-case.	Not for active implanted electronic devices, epilepsy/seizure disorder, metal implant at the treatment site, open skin/infection, or adhesive allergy. Do not use while driving or operating machinery.
Restiffic foot orthosis Simpler / cheaper	Adjustable pressure on the abductor hallucis and flexor hallucis brevis muscles in the foot.	FDA De Novo authorization; prescription-only. Manufacturer currently sells direct after receiving a prescription, lists a 60-day satisfaction guarantee, and says it is not generally insurance-covered. Current listed price: about $249.	FDA review noted limited clinical data, including a six-week study. Avoid or obtain medical clearance with DVT history, poor circulation, neuropathy, significant swelling, fragile skin, wounds, diabetes, heart failure, or kidney disease.

Important distinction

“FDA-cleared/authorized” means the device passed a regulatory pathway for its intended use; it does not guarantee that it will help a particular person. Nidra has the stronger modern sham-controlled evidence. Restiffic is a reasonable lower-cost discussion option but has less robust and shorter-duration evidence.

3. Overseas and non-FDA options

Device	Country / status	What I could verify	Assessment
TheraPulse	United Kingdom; marketed in the UK/EU and internationally	Portable, rechargeable device using low-energy vibration, with 10 treatment modes. The manufacturer says it can be worn under clothing or at night and reports an 88% reduction in muscle activity in its clinical trials. I did not find a modern, large, independent sham-controlled RLS trial in the available sources.	Potentially purchasable overseas; evidence uncertain. Treat manufacturer claims as preliminary, not equivalent to Nidra trial evidence. Check shipping, returns, electrical certification, and clinician compatibility before importing.
Relegs	Netherlands; historically CE-marked Class IIa	Reported as an electronic calf “band-aid” delivering electrical pulses through an electrode patch to activate sensory nerve fibers. Historical reporting says a small batch began selling in 2020 and the company planned a broader Dutch launch.	Interesting but availability unclear. I could not verify a reliable current storefront or current post-market evidence. Do not confuse historical CE certification with current availability or proven effectiveness.
Generic European TENS / EMS products	Widely sold internationally	Some use electrical stimulation, but generic TENS placement and waveforms are not the same as the calibrated peroneal-nerve stimulation used in TOMAC trials.	Not an interchangeable substitute. Avoid self-experimenting near the fibular head without professional guidance, especially with implants, neuropathy, seizures, or poor skin sensation.

Import warning

A device sold overseas may lack FDA authorization, U.S. electrical-safety labeling, U.S. warranty/service, compatible power accessories, or a clear route for adverse-event reporting. Importing one does not make it illegal for personal use in every circumstance, but it shifts quality, compatibility, and medical oversight risks to the buyer. Ask the treating clinician before use.

4. Other device categories

Pneumatic compression boots

A small randomized study and an earlier pilot study found improvement when sequential compression was used for about an hour in the evening. However, the studies were small, and ordinary recovery boots are not necessarily authorized to treat RLS. Consider only after checking circulation and clot risk with a clinician.

Vibration pads

Older guidance allowed vibrating pads as a low-certainty option for subjective sleep improvement. The once-marketed Relaxis pad is no longer a dependable new-purchase option. Used devices may lack support, hygiene assurance, or replacement parts.

Massage guns / weighted blankets

May feel soothing for some people, but I found no comparable RLS-specific evidence or regulatory authorization. They should be treated as comfort measures, not established treatments.

Red light / magnetic gadgets

I found no credible evidence that these devices treat RLS. Be especially cautious with products making broad claims without published controlled trials.

5. Safety and medication review

Do not stop medication abruptly

If a necessary medication worsens RLS, the prescriber may sometimes adjust its timing, dose, or substitute another drug. Do not stop antidepressants, psychiatric drugs, anti-nausea medicines, or other prescriptions without the prescriber.

The 2025 American Academy of Sleep Medicine guideline says clinicians should address exacerbating factors, including alcohol, caffeine, antihistaminergic medicines, serotonergic medicines (including some antidepressants), antidopaminergic medicines, and untreated obstructive sleep apnea.

If he takes pramipexole, ropinirole, rotigotine, or levodopa, ask about augmentation: symptoms progressively starting earlier, spreading to new body areas, or becoming more severe. This can be a medication-related worsening rather than ordinary loss of effectiveness.

Iron should be assessed with actual ferritin and transferrin saturation. RLS treatment thresholds can be higher than ordinary anemia thresholds; the AASM consensus uses oral or IV iron when ferritin is ≤75 ng/mL or transferrin saturation is <20%, and generally IV iron when ferritin is 75–100 ng/mL. His clinician must interpret this in context and avoid unnecessary iron.

6. Questions to take to his clinician

Is his diagnosis definitely RLS rather than another movement, nerve, vascular, or medication-related condition?
Could any current medicine be worsening symptoms, and can timing or substitution be considered without destabilizing the condition being treated?
Could this be dopamine-agonist augmentation?
Is he a candidate for Nidra, and is it available and reimbursable where he lives?
Would Restiffic be safe given his circulation, skin sensation, diabetes, kidney, heart, and clot history?
Would a properly selected pneumatic compression trial be safe, or should it be avoided?
What are his current ferritin and transferrin-saturation values, and is additional iron actually indicated?
Does he need evaluation for sleep apnea?